A Split Body Study of the Effects of Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2018
At a glance
- Drugs Apremilast (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 12 Sep 2018 Planned End Date changed from 1 Jun 2019 to 1 Aug 2019.
- 12 Sep 2018 Planned primary completion date changed from 1 Nov 2018 to 1 Aug 2019.
- 25 Apr 2017 New trial record